Share Prices & Company Research

Stockbroking

Beximco Pharmaceuticals

Current Price 46.80p Bid 46.20p Ask 50.00p Change -0.82%
Last Updated: 26/05/2019 17:59. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Beximco Pharmaceuticals Limited was founded in 1976 and based in Dhaka, Bangladesh. Beximco Pharma manufactures and sells generic pharmaceutical formulation products and active pharmaceutical ingredients. The Company also undertakes contract manufacturing for multinational and leading global generic pharmaceutical companies. The Company operates from a 23 acre site in Dhaka and has manufacturing facilities for producing various drugs in different delivery systems such as tablets, capsules, liquids, semi-solids, intravenous fluids, metered dose inhalers, dry powder inhalers, sterile ophthalmic drops, prefilled syringes, injectables, nebuliser solutions, oral soluble films etc. Ensuring access to quality medicines is the powerful aspiration that motivates 3,500 employees of the Company. Beximco Pharma's state-of-the-art manufacturing facilities are certified by global regulatory authorities of USA, Europe, Australia, Canada, GCC and Latin America, among others. The Company's products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in South East Asia, including Singapore, Thailand, Taiwan, Malaysia, Indonesia, Philippines and Hong Kong; Africa, including South Africa, Mauritius, Kenya, Ghana, Ethiopia, Uganda and Nigeria; Central Asia, including Azerbaijan; Middle East, including Kuwait and Jordan; Pacific Island countries; Latin and Central American countries; Europe, including Austria, Germany and Romania; Australia and North America, including the USA and Canada.

Financial Highlights Year Ended 30/06/2018

Turnover
£17,716.72m
Operating Profit
£4,026.17m
Dividend Yield
2.58
Dividend Per Share
1.25
Dividend Cover
5.00
P/E Ratio
7.76

Stock Details

EPIC
BXP
ISIN
US0885792061
Shares in Issue
405,556,445
Market cap
£196.70m

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
48.10p
Bid Price
46.20p
Ask Price
50.00p
Volume
4000
Change Today
-0.40p
% Change Today
-0.82%
Open
46.80p
Previous Close
48.10p
Intraday High
46.80p
Intraday Low
46.80p
52 Week High
55.00p
52 Week Low
43.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Beximco Pharmaceuticals Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Tangible Assets
30,524.7
24,472.5
Intangible Assets & Goodwill
1,827.4
463.0
Investments & Other Non-Current Assets
42.6
17.9
Total Non-Current Assets
32,394.7
24,953.3
Inventory
5,058.9
3,468.1
Trade & Receivables
2,761.5
2,167.3
Cash & Receivables
393.7
275.0
Other Current Assets & Assets Held for Resale
3,130.1
3,220.4
Total Assets
43,738.9
34,084.1

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Short Term Liabilities
9,018.2
3,406.0
Long Term Liabilities
7,368.9
5,605.7
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
16,387.1
9,011.7

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Net Assets
27,351.8
25,072.4

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Share Capital
4,055.6
4,055.6
Minority Interests
269.9
0.0
Retained Earnings
14,608.7
12,568.7
Share Premium Account
5,269.5
5,269.5
Other Equity
3,148.2
3,178.7
Total Equity
27,351.8
25,072.4

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Cashflow from Operating Activities
1,819.1
2,634.0
Cashflow Before Financing
-4,801.6
84.5
Increase / Decrease in Cash
101.6
53.9

Income (£m)

Data has been provided by AJ Bell

Reporting Date
30 Jun 2018
30 Jun 2017
Turnover
17,716.7
15,508.8
Cost of Sales
9,430.7
8,323.9
Gross Profit
8,286.0
7,184.9
Operating Profit
4,026.2
3,448.2
Pre-Tax Profit
3,361.3
2,891.5
Profit / Loss for the Year
2,532.7
2,226.7

Dividend History

Data has been provided by AJ Bell

Period
Ex-Dividend Date
Payment Date
H1 Dividend
03 Nov 2016
09 Dec 2016
H2 Dividend
12 May 2016
04 Jul 2016
H2 Dividend
21 May 2015
13 Jul 2015
H2 Dividend
15 May 2014
14 Jul 2014
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.